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Abstract
In Madagascar, Newcastle disease (ND) has become enzootic after the first documented epizootics in 1946, with recurrent
annual outbreaks causing mortality up to 40%. Four ND viruses recently isolated in Madagascar were genotypically and
pathotypically characterised. By phylogenetic inference based on the F and HN genes, and also full-genome sequence
analyses, the NDV Malagasy isolates form a cluster distant enough to constitute a new genotype hereby proposed as
genotype XI. This new genotype is presumably deriving from an ancestor close to genotype IV introduced in the island
probably more than 50 years ago. Our data show also that all the previously described neutralising epitopes are conserved
between Malagasy and vaccine strains. However, the potential implication in vaccination failures of specific amino acid
substitutions predominantly found on surface-exposed epitopes of F and HN proteins is discussed.
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Introduction
Newcastle disease (ND) is a highly contagious and widespread
disease which causes severe economic losses in domestic poultry,
especially in chickens [1,2]. In Africa, ND is the major constraint
to rural chicken development. This disease is listed as a notifiable
disease by the World Organisation for Animal Health (OIE) [3].
The causative agent of the disease is Newcastle disease virus
(NDV), also designated avian paramyxovirus serotype 1 (APMV-
1), which belongs to the genus Avulavirus within the family
Paramyxoviridae [4,5]. The genome comprises a single stranded
negative sense RNA that encodes the RNA-dependent RNA
polymerase (L gene), the haemagglutinin-neuraminidase (HN
gene), the fusion (F gene) and matrix (M gene) proteins, the
phosphoprotein (P gene) and the nucleoprotein (NP gene). The
genome is predicted to be 15186, 15192 or 15198 nucleotides (nt)
in length, always a multiple of six nt, which fulfils the so-called ‘rule
of six’ for optimised replication [6,7,8,9,10]. Based on the analysis
of nucleotide sequence of the F protein gene, 10 different
genotypes (I–X) or 6 different lineages (1–6) of NDV have been
identified so far. The genotypes VI (lineage 4) and VII (lineage 5)
are further divided into eight (a–h) and five (a–e) subgenotypes/
sublineages, respectively [11,12,13,14,15,16,17,18,19]. APMV-1
strains can be categorised according to their virulence into highly
(velogenic), intermediate (mesogenic) or non virulent (lentogenic).
The pathogenicity of APMV-1 isolates is assessed on the basis of in
vivo tests including the intracerebral pathogenicity index (ICPI) in
1-day-old chickens, the mean time of death (MDT) of embryo-
nated specific-pathogen-free hen’s eggs after inoculation and the
intravenous pathogenicity index (IVPI) in 6-week-old chickens [3].
The molecular basis for these different levels of pathogenicity is
known to be linked to the sequence of cleavage site of the
precursor fusion protein (F0). At this position, a pathogenic NDV
strain (velogenic and mesogenic) has at least one extra pair of basic
amino acids motif
112X-R-X-R/K-R-F
117 [20] and can be cleaved
by a wide range of proteases of the furin family in different host
cells [21].
Since ND was first described in 1926, three worldwide
panzootics have occurred [20]. The first panzootic (1926 to
1960) was caused by viruses belonging to genotypes II–III–IV and
the second (1960 to 1973) and third (1970–1980) ones by
genotypes V–VI. Moreover, severe outbreaks in Western and
Southern Europe [22], [23], South Africa [24] and Taiwan [25] in
the 90’s were caused by genotype VII, the currently circulating
genotype in Asia, Africa and Europe. In Madagascar, ND was
firstly described in 1946 [26] and since then, outbreaks were
regularly reported on the whole island mainly in the rural poultry
sector [27]. While the vaccination rate is estimated to reach 100%
in commercial farms in Madagascar, probably less than 10% of
the free-range poultries are duly vaccinated. ND is considered to
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13987induce more than 40% of mortality in such non protected poultries
[28]. In spite of the importance and endemicity of ND in
Madagascar, no data is available about the virus variants involved
in clinical cases and/or maintenance of this disease in the island.
In this study, four APMV-1 strains from Madagascar (named here
MG group) were isolated in 1992 and 2008 and were molecularly
characterised. Two of these strains were fully sequenced while the
two other ones had only F and HN genes sequenced. Phylogenetic
analyses showed that the MG group strains clustered within a new
distinct genotype, closer to old genotypes. This study represents
the first molecular characterisation of APMV-1 circulating in
Madagascar and provides evidence on the existence of a new
genotype close to an old died out genotype.
Materials and Methods
Ethics statement
All animal experiments (ICPI tests) were conducted according to
internationally approved OIE standards, under authorizations set
forth by the director of the veterinary services of Co ˆtes d’Armor on
behalf of the Prefect of Co ˆtes d’Armor (Nu 22-18) and the Director
of the veterinary services of He ´rault on behalf of the Prefect of
He ´rault (Nu 34-114). Certificates of authorization are available
from the authors upon request.
Origin and isolation of virus strains
Synthetic information about the Madagascar isolates is
provided in Table 1. An ‘‘old’’ strain (MG-1992) was first
isolated by the Centre National de Recherche Applique ´e au De ´veloppement
Rural (FOFIFA-DRZV) in 1992, after suspicion of avian influenza
or ND in a dead fowl assumed to be vaccinated against ND (La
Sota vaccine). The three other isolates were collected in
Madagascar during a surveillance programme in African
wetlands led in 2007 and 2008 by the Centre de Cooperation
Internationale en Recherche Agronomique pour le De ´veloppement (CIRAD),
Montpellier, France and the FOFIFA-DRZV, Antananarivo,
Madagascar. The MG-725/08 strain was recovered both from
cloacal and tracheal swabs from an unvaccinated apparently
healthy chicken. Another strain (MG39-04/08) was isolated from
a dead chicken in a commercial farm: this chicken was initially
vaccinated with the HB1 strain and boosted with the La Sota
vaccine. The last isolate (MG-Meola/08) was recovered from a
non vaccinated backyard poultry.
Samples of brain tissues or cloacal/tracheal swabs positives in
the APMV-1 specific PCR (protocol based on M gene recom-
mended by the reference laboratory of the OIE) were further
processed for virus isolation by inoculation into 9-day old chicken
embryonated eggs. All isolates were grown in less than 3 passages
on eggs and tested by PCR before molecular sequencing.
In vivo assay
The intracerebral pathogenicity index (ICPI) was determined
according to international OIE standards (OIE, 2009) for two
isolates of the MG group (MG-1992 and MG-725/08). Briefly,
fresh allantoic fluid with a HA titre .1/16 was diluted 10
21 in
sterile isotonic saline buffer. Following filtration through 0.22 or
0.45 mm filters this diluted virus was injected intracerebraly
(0.05 ml) into 10 one day-old chick hatched from embryonated
SPF hens’ eggs. Whereas each inoculum was checked for lack of
bacterial and fungal contamination following culture on trypto
casein soja and sabouraud media, the birds were examined at 24h
intervals for 8 days and given a score (0, 1 or 2) according to their
status (respectively healthy, sick or dead). The ICPI was calculated
as the total of individual scores during 8 days divided by 80 (the
number of days x the number of chickens).
RNA isolation, cDNA synthesis and nucleotide
sequencing
For reverse transcription and PCR reactions, RNA was
extracted from allantoic fluids by using the NucleospinH RNA
Virus kit (MachereyNagel) following the manufacturer’s instruc-
tions. The cDNA transcriptions were carried out by using the
First-strand cDNA synthesis kit (GE Healthcare). Six pairs of
oligonucleotide primers previously published [13,29] or designed
in this study (Table S1 in supporting material), using BioEdit
version 7.0.9.0 and Vector NTI software version 11.0 (2008
Invitrogen Corporation), were used to amplify six overlapping
DNA fragments to generate the complete sequences of F and HN
protein genes. All DNA fragments were sequenced in both
directions by Cogenics Genome Express S.A. (Meylan-France).
For the rest of the genome, 23 overlapping PCR were realized
with Platinum Taq DNA polymerase (PlatinumH Taq DNA
Polymerase High Fidelity, Invitrogen). The DNA sequences were
determined in both senses using the Big dye Terminator v3.1 cycle
sequencing kit (Applied Biosystems) according to the manufactur-
er’s instructions and using the same primers as to PCR reactions.
Alignment of the F and HN predicted amino acid
sequences and phylogenetic analyses
The sequences of the four isolates were compared with
previously reported NDV sequences representative of different
genotypes available in GenBank. A 374 nucleotide (nt) fragment of
a variable portion of the F protein gene (47 to 421), including the
F0 cleavage site and a 1713 nt (92 to 1805) of HN gene were
processed by Clustal W [30] in alignX program included into
Vector NTI software suite (version 11.0). The nucleotide sequence
databank accession numbers of ND viruses used in this study are
shown in supporting Table S2 of supporting material. Alignment
of complete amino acid sequences of F and HN was processed by
Table 1. NDV isolates from Madagascar used in this study.
Strain Code Region/Country Statut Sequence
Clinic Vaccine size (nt) Covering full genes
APMV1/Chicken/MG/1992 MG-1992 Ivato-Madagascar Dead laying chicken La Sota 15082 NP, P, M, F, HN and L
APMV1/Chicken/MG/725/2008 MG-725/08 Mahitsy-Madagascar Healthy rural poultry NV
a 15097 NP, P, M, F, HN and L
APMV1/Chicken/MG/39-4/2008 MG-39-04/08 Ivato-Madagascar Dead broiler chicken La Sota 4249 F and HN
APMV1/Chicken/MG/Meola/2008 MG-Meola/08 Tsarahonenana-Madagascar Sick grower fighter cock NV 3966 F and HN
a: not vaccinated.
doi:10.1371/journal.pone.0013987.t001
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MEGA4 software (version 4.1). Phylogenetic relationships and
nucleotide divergence analyse (intra and inter genotype) were
established with MEGA4 [31] using the Kimura 2-parameter
correction in which the transition/transversion ratio was estimated
from the data [32]. The statistical significance of the tree topology
generated with the neighbor-joining algorithm was evaluated by
1,000 bootstrap resamplings of the data [33]. To confirm the
robustness of the genetic groupings obtained by the phylogenetic
analysis on the partial fragment (374 nt) a phylogenetic tree based
on full-genome sequences of two isolates of the MG group (MG-
1992 and MG-725/08) and 86 other full-genome sequences
belonging to different genotypes were further carried out using the
same parameters used for F and HN analyses. Putative
recombination events in the two full-genomes of MG isolates
were examinated using the recombination detection program
RDP 3.0b [34].
Results
Determination of in vivo pathogenicity (ICPI test)
ICPI values were determined for the isolates MG-1992 and
MG-725/08. These isolates showed a very high ICPI of 1.9 being
classified into a velogen-type NDV (Table 2).
Sequencing MG, genome organisation and phylogenetic
analyses
The sequence covering the six open reading frames (ORFs: NP,
P, M, F, HN, L), without the complete sequence of the 39-leader/
59-trailer of two MG strains, MG-725/08 and MG-1992, and the
complete nucleotide sequence covering the F and HN genes of two
other strains, MG-39-04/08 and MG-Meola/08, obtained in this
work were analysed along with those of reference strains retrieved
from GenBank.
Class II APMV-1 isolates have two genome lengths. The
genotypes considered as ‘‘early’’ (1930–1960; genotypes I to IV,
IX and H33(W)) contain 15,186 nt and recent genotypes (that
emerged after 1960, genotypes V–VIII and X) contain 15,192 nt
(15,186 nt+6 nt in the 59 non-coding region or NCR of NP gene)
[12]. As seen in recent genotypes, the MG group has six
nucleotides insertion in the 59 non-coding region (NCR) of the
nucleoprotein gene between nucleotides 1647 and 1648 increasing
its genome size to 15,192 nt (Figure 1).
The phylogenetic analysis of F gene (Figure 2) shows that the
MG strains are grouped together. They are closer to the ‘‘old’’
genotype IV but may be distant enough to constitute a new
genotype, proposed here as genotype XI or lineage 3g. This
phylogenetic topology created using 374 nt fusion gene fragments
was confirmed by phylogenetic analyses based on the full NH gene
(data not shown) and on the full-genome sequences of two isolates
of the MG group (MG-1992 and MG-725/08) and 86 other full-
genome sequences belonging to different genotypes (Figure 3).
Based on a partial fragment of F gene (374nt), genetic
divergences between the MG group and the other ten genotypes
(I to X) are presented in Table 3. The F nucleotide sequences
divergence within the MG group was 5%. The maximum intra-
genotype divergence in old genotypes was 7% (genotypes I and IV)
whereas the maximum intra-genotype divergence in recent
genotypes was 9% (genotype VIII). The lower genetic divergence
found between the MG group and another genotype (genotype IV)
was 12%. In contrast, the higher divergence (25%) was observed
with the genotype II that includes the La Sota vaccine strain. Since
the maximal intra-genotype divergence ever observed does not
exceed the minimal divergence of the MG group with other
genotypes, our data support the hypothesis that MG group
constitutes a distinct new genotype. This new genotype is further
confirmed by the phylogenetic analysis of the full-genome
sequences (Figure 3). Surprisingly, the phylogenetic analysis of
whole genome sequences also show that the genotype IV does not
cluster with the ‘‘old genotypes’’ (I, II, III, IX), as suggested before
(Czegledi et al., 2006), but rather with ‘‘recent genotypes’’
(V,VI,VII).
The analysis of the F1/F2 protein cleavage site sequence of the
four MG isolates showed that they share an original cleavage site
motif formed by five arginines (R)
112R-R-R-R-R
116 at the C
terminus of F2 exhibiting an atypical Q/R substitution at position
114 followed by a phenylalanine (QF
117) at position 117 of the F1
amino terminus (Table 2). This motif is considered as a velogenic
motif according to OIE [3]. Other virulent-like cleavage motifs
with five basic amino acids have been described for genotypes VI,
VII and VIII that are formed by a combination of arginine (R) and
lysine (K) residues like
112R-R-K-K-R
116*F
117 or
112R-R-R-K-
R
116*F
117 [35,36,37,38,39]. The substitution of a glutamine
residue by a basic amino acid (R or K), corresponding to
nucleotide mutation at positions 4885 or 4886 (CAGRCGGo r
AAG) is only found in some strains pertaining to the ‘‘recent’’
genotypes VI or VIII.
Like other NDV strains, the complete length of F and HN genes
of MG group viruses were 1792 nt and 2002 nt, respectively. The
F gene of all MG group isolates showed a single open reading
frame (ORF) beginning with a unique double start codons
44AUGAUG
49 and ending at position 1705 followed by the
UGA stop codon. Consequently, the open reading frame of the F
gene may extend to 1665 nt rather than 1662 nt usually found in
other reference strains.
T h ep r e d i c t e da m i n oa c i ds e q u e n c e so ft h ec o m p l e t eFg e n eo ft h e
four MG isolates was analysed and compared with different strains
pertaining to genotypes I to IX (Table 4). This analysis showed that
all seven neutralising epitopes critical for both structure and function
of the protein positioned at individual residues D
72,E
74,A
75,K
78,
A
79,L
343 and the stretch of amino acids
157ILRLKESIAATNEAV-
HEVTDG
171, are conserved [40,41,42]. The twelve cysteines
residues placed at positions 25, 76, 199, 338, 347, 362, 370, 394,
399, 401, 424 and 523 [43] and the predicted N-glycosylation sites
(Asn-X-Ser/Thr or N-X-S/T) where X is any amino acid except
aspartic acid or proline, located at positions
85N-R-T
87,
191N-K-T
193,
366N-T-S
368,
447N-I-S
449,
471N-N-S
473 and
541N-N-T
543 [44,45] are
also conserved in the MG group. However, the analysis of predicted
amino acid sequence of a F proteinfragment (residues 0–553 for MG
isolates or 1–553 for the other strains) revealed substitutions in the
MG isolates found also in other strains clustered in the old genotypes
(I–IV and IX) like T
16RI, E
104RG, Q
195RRa sw e l la ss u b s t i t u t i o n s
found in recent genotypes (V to VIII) like V
81RL, A
106RV, V
118RI
and V
350RI. In addition, the MG group has fifteen specific amino
acid residues in F protein which are not found in any other genotype
(Table 4). Twelve (80%) of these amino acids are located in the head
of trimeric NDV-F protein M
0R-, W
8RR, P
15RL, S
272RN,
M
289RL, S
311RT, R
364RS, T
371RM, L
384RM, I
397RT, T
409RS
and H
411RN. The three remaining substitutions S
244RG, K
476RN,
and I
522RAa r el o c a t e di nt h es t a l ko ft he F-trimeric structure
(Figure 3). Interestingly, the three MG strains recently isolated in
2008 share eight additional amino acids (Q
4RK, F
12RP, S
28RL,
R
73RK, S
79RA, E
110RG, V
202RI, S
258RNa n dH
337RY)
compared with the strain isolated in 1992.
According to the virulence of NDV strains, HN monomeric
protein sequences possess different amino acid sequence lengths:
571, 577, 581 and 616 [46]. The ORF of HN gene of MG group
strains begins at position 92 and ends at position 1714. This HN
New Genotype APMV-1
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Strain Class or Genogroup ICPIa value Cleavage site
Identification Accession number r---------------------------------- F2R * rF1-------R
112 113 114 115 116 117 118
RRQRR * FI
DE R49/99 DQ097393 Cl I (6) nd G - - G - * L V
GO1US DCKI AY626266 Cl I (6) nd E - - E - * L V
Herts33/56 (PEI) AY170140 H33 (w)
b n d ----- * --
Herts33 (L) AY170138 H33 (w)
c n d ----- * --
Ulster/67 AY562991 I (1) 0,0 G K - G - * L -
Ethiopie Panvac (2/P2) AY175720 I (1) 0,0 G K - G - * L -
PHY-LMV42/66 DQ097394 I (1) 0,0 G K - G - * L -
Hitchner B1 AF309418 II (2) 0,2–0,5 G - - G - * L -
La Sota AF077761 II (2) 0,2–0,5 G - - G - * L -
Zimbabwe AV862/95 AY175710 II (2) nd G - - G - * L -
Zambie AV 72/95 AY175708 II (2) nd G - - G - * L -
Mukteswar EF201805 III (3a) 1,4 - - - - - * - -
Guangxi5/2000 DQ485259 III (3a) nd - - - - - * - -
Herts/33 (de Leeuw) AY741404 IVea (3b) 1,99 - - - - - * - -
BG 60–81 AF402129 IVea (3b) nd - - - - - * - -
BG 5–67 AF402104 IVbg (3b) nd
SIMF/64 AJ243390 IVbg (3b) nd - - - - - * - -
Soudan 72 AV 2203 AY135753 IVit (3b) nd - - - - - * - -
DE-191/77 AF525378 IVit (3b) nd - - - - - * - -
IT-48/68 AF297969 IVit (3b) nd - - - - - * - -
MA-307/77
c EU604259 IV (3b) nd - - - - - * - V
MA-13/02
c DQ096598 IV (3b) nd - - - - - * - V
Tanzania AV 1300/95 AY175687 V (3c) nd - - - K - * - V
Mexico468/01 EU518685 V (3c) nd - - - K - * - V
Brasil AV1769/90 AY175649 V (3c) nd - - - K - * - V
HR-111/01 AY150162 VI (4) nd K - - K - * - -
Soudan SD-4/75 AY151384 VI (4) nd - - - K - - -
Egypte EG-3/87 AY150111 VI (4) nd - - - K - - -
DE 61/93 AY150135 VI (4) nd - - K K - * - -
Strain NA DQ659677 VII (5) nd - - - K - * - -
MZ 13/94 AF136775 VII (5) nd - - - K - * - -
Botswana ZA148/UP/98 AY210507 VII (5) nd - - - K - * - -
South Africa ZA606/UP/00 AY210497 VIII (3d) nd - - - K - * - -
Singapore SG-4H/65 AF136786 VIII (3d) nd - - - K - * - V
F48E9 AY508514 IX (3e) 1,89 - - - - - * - -
SBD02 DQ227252 IX (3e) nd - - - - - * - -
TJ03 DQ227244 IX (3e) nd - - - - - * - -
TW/69 AF083959 X (3f) nd - - - K - * - -
TW/95-3 AF083970 X (3f) 1,68 - - - K - * - -
MG-1992 HQ266603 XI (3g) 1,9 - - R - - * - V
MG-725/2008 HQ266602 XI (3g) 1,9 - - R - - * - V
MG-39-4/2008 HQ266605 XI (3g) nd - - R - - * - V
MG-Meola/2008 HQ266604 XI (3g) nd - - R - - * - V
a: ICPI intracerebral pathogenicity index;
b: Weybridge line [77];
c: [8]. The isolates from Madagascar that were subjected to analysis in this work are in bold.
doi:10.1371/journal.pone.0013987.t002
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strains [14,42,46,47]. In this study, different HN sequence strains
pertaining to genotypes or subgenotypes available in Genbank (I to
VII and IX) with different lengths were aligned with the MG
group sequences (data not shown). The results showed that all the
previously described neutralising epitopes
193LSGCRDHSH
201,
R
263,D
287,K
321,
332GR
333,
346DEQDYQIR
353,K
356,N
481,D
494,
513RITRVSSSS
521, G/D
569 [48,49,50] are not modified in MG
group strains. The three amino acid E
401,R
416,Y
526 essential for
receptor binding site [51,52] and the neuraminidase activity site
represented by functional triarginyl cluster at positions
174RI
175,
R
416,R
498, the amino acid sequence in region
234NRKSCSI/V/
L
240 [53] as well as the regions
314FXXYGGV/L/M
320 -
399GA/
SEGRI/V/L
405 involved in hemagglutinating activity [54], were
likewise conserved in the MG strains. In addition, the MG strains
have preserved the thirteen cysteines residues in the linear
sequence of the ectodomain 123, 172, 186, 196, 238, 247, 251,
344, 455, 461, 465, 531, 542 [43] and the eleven sialic acid
receptor binding sites R
174,I
175,E
258,Y
299,Y
317,E
401,R
416,R
498,
Y
526,R
516,E
547 [52]. Except the cysteine residue at position 123,
all these amino acid cited before are located in the globular head
on the HN spike. Otherwise, the analysis of HN amino acid
sequences showed that the four MG strains contain also eleven
specific amino acid residues that are different from those of any
other NDV strain (Table 4). Seven of these A
24RV, T
34RV,
L
39RI, ERV
62,R RQ
78,M
81RV and S
98RN are located in the
124 first N-terminal amino acids, including the cytomere (position
1 to 20), the transmembrane region (position 21 to 49) and the
stalk (position 50 to 124) of HN protein. The four last
characteristic amino acids E
147RD, R
263RN, I
328RT, R
539RK
are localized on the globular head of the protein (Figure 4). In
addition, the MG-725/08 strain has six additional specific
substitutions H
3RR, T
64RS, V
117RA, R
377RK, A
380RT and
A
510RS when compared with the three other MG strains (Meola/
08 MG 39-04/08 and MG-1992).
The analysis of recombination events by the RDP 3.0b software
[34] was performed among Malagasy strains and other full
sequences of APMV-1 of class II (genotypes I, II, III, IV, V, VI,
VII and XI) and one strain of class I. No recombination events
were detected in the Malagasy strains.
Discussion
In this study, complete genome or complete genes of F and HN
proteins of four NDV strains isolated in Madagascar (MG group
strains) were sequenced and analysed. These strains are the first
Madagascar isolates characterised at the molecular level. Among
them, the strains MG 1992 and MG39-04/08, isolated in 1992
and 2008 respectively, were recovered from vaccinated chickens.
The salient findings of this work are the strong evidence that
MG isolates constitute a new genotype closer to the old genotypes
that were circulating 50 years ago and responsible for the first
pandemic of ND in the world. The MG group strains are
branched to the genotype IV cluster from which strains have
never been detected since 2002. [12]. The partial sequence of the
F gene (374 nt at positions 47 to 420) is regarded as a standard
criterion for NDV genotyping of isolates present in various parts
of the world [55]. Based on percentage of genetic divergence of
this F gene fragment, the maximum intra-genotype nucleotide
variations within any old genotype (below 7%) is lower than the
minimum nucleotide distance found between these genotypes and
the MG group (12% to 25%). This is clearly supporting that MG
isolates are closely related to genotype IV but distant enough to
constitute a new genotype or lineage, named here genotype XI or
lineage 3g in reference to the two last genotypes IX [42] and X
[14] (lineages 3e and 3f, respectively) identified in Asia. The
cluster topology of the MG group strains based on the F gene was
confirmed by the phylogenetic analysis based on full-genome
sequences of two isolates of the MG group (MG-1992 and MG-
725/08) and 86 other full-genome sequences belonging to
different genotypes.
Whole genome sequencing of two MG strains revealed a
genome size of 15,192 nucleotides meaning that this group has an
insertion of six nucleotides into the 59 NCR of the nucleoprotein
gene, characteristic of recent genotype strains. In addition, MG
isolates have an arginine at position 114 (R
114) of the F protein
cleavage site found in some recent isolates but never in old strains.
MG viruses have also a substitution V
118RI, which is considered
to be a feature of the genotype V [56,57] that belongs to the recent
genotypes cluster. In contrast, MG isolates share a molecular
substitution characteristic of old genotypes as E
104RG, in F
protein [42,58]. Although Yu et al [58] claimed that E
104RG
substitution caused a dramatic change responsible for the
evolution of the old genotypes towards the recent genotypes, we
do not found such mutation in the MG strains nor in the strains of
genotypes IX and X, phylogenetically closer to the old genotypes.
Moreover, the phylogenetic analysis based on full-genome
sequences unexpectedly showed that the genotype IV, and the
newly proposed genotype XI as well, are not branched in the ‘‘old
genotypes’’ cluster (I, II, III, IX), as observed in phylogenetic trees
constructed based on the 374 nt fragment of F gene. All together,
our results can suggest that genotypes IV and XI are intermediates
Figure 1. Alignment showing the inserted sequence at in the position 1647 in 59 non-coding region of NP gene.
doi:10.1371/journal.pone.0013987.g001
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genotypes or lineages clustering based on the 374 nt fragment of F
gene is probably inadequate to classify NDV isolates.
All MG isolates show the same fusion protein cleavage motif
112R-R-R-R-R*F
117. To our knowledge, this atypical virulent-like
cleavage site has never been reported before in APMV-1 strains.
However, it is found in other paramyxoviruses (Rubulavirus) like the
simian virus type 5 [45,59]. In addition, the presence of a
phenylalanine at position 117 (QF
117) in the MG isolates was
previously described as being a possible contributor to neurological
effects [10]. Thereafter, the length of amino acid sequence of the
haemagglutinin-neuraminidaseprotein(571aa)isalsocharacteristic
of virulent strains [46,60,61]. The prediction of virulence based on
the F cleavage site pattern was confirmed by in vivo tests that has
resulted in a high ICPI value (1.9), close to the maximum of 2, with
the two strains tested (MG-1992 and MG-725/08). In spite of the
established virulence of the MG-725/08 strain, it was recovered
both from cloacal and tracheal swabs from an unvaccinated and
apparently healthy chicken. However, the possibility that this
chicken was sampled during the incubation period of the infection
or was partially protected by a previous infection with an avirulent
or vaccine strain that circulate in the field cannot be ruled out.
Figure 2. Phylogenetic tree (unrooted) of nucleotide sequences based on a 374-nt sequence (position 47–421 nt) of the F gene.
Phylogenetic relationships of MG group strains with previously published sequences in Genbank. The evolutionary history was inferred using the
Neighbor-Joining method [33]. All results are based on the pairwise analysis. Analyses were conducted using the Kimura 2-parameter method in
MEGA4 [31,32] with 1,000 bootstraps [76]. The isolates from Madagascar that were subjected to analysis in this work are in bold and red. Genotype or
lineage groupings are indicated on the right.
doi:10.1371/journal.pone.0013987.g002
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e13987Based on neutralising tests and cross-protective analyses, it is
accepted that APMV-1 exists as a single serotype [62]. Therefore,
the genetic variations of the virus are not expected to result in
vaccination failure. However, different levels of cross-protection
have been observed in chickens vaccinated with the vaccine strain
La Sota belonging to the genotype II and challenged with different
wild-type strains [55]. Sporadic cases of ND in commercial farms
vaccinated with this vaccine were previously reported in China
[7,58], in southern California and adjacent states [63], in Mali
[64], Cameroon, Nigeria and Burkina Faso [65]. Whether these
observations are related to a reduction of vaccine efficacy or an
improper vaccine use in the field remains unclear. It is however
possible that NDV strains responsible for ND sporadic outbreaks
in vaccinated chickens can escape the immune responses
[16,18,66] and thus contribute to the emergence of new genotypes
[42]. This vaccine failure has been announced by Alexander et al.,
[67] during the third panzootic of ND (1981–1983) in Europe in
which the pigeons immunized with live NDV B1 vaccine were not
well protected against pigeon paramyxovirus isolates (genotype
VI). It is also known that the immune pressure imposed by the
vaccination may be selecting virulent variant forms of NDV [68].
Many authors have demonstrated that current vaccines prevent
disease but cannot stop viral shedding [47,63]. The NDV strains
currently circulating (subgenotype VIId prevalent in Asia, Europe
and Africa) and the genotype XI predominant in Madagascar
have a significant genetic distance (21% to 25%, respectively), with
the widely used vaccine strain La Sota pertaining to the genotype
II. These genetic differences and a consequent suboptimal
vaccination may be responsible for sporadic cases of ND in
vaccinated poultry flocks in Madagascar. In contradiction with
this, multiple sequence alignments of the four MG isolates made
with several published sequences including the La Sota strains and
HB1, members of genotype II (data not shown) revealed that all
the neutralising epitopes identified so far and the predicted
attachment receptor sites in the F and HN glycoproteins are
conserved. However, all MG group strains possess fifteen and
eleven original amino acid substitutions on F and HN proteins,
respectively. Some of these substitutions occurred in the globular
head of the proteins. Furthermore, 5 out of the 8 mutations in the
head of the F protein are concentrated in a short invariable region
at position 364–411, suggesting that the observed mutations are
actually selected over time by the host immune responses. It is
supposed that these substitutions should have resulted in antigenic
drift and major changes in the protein conformation [69],
particularly the changes in amino acid polarity as T
34RV,
E
62RV in HN protein and S
244RG in F protein. The HN/F
protein interaction for fusion promotion involves the HN head
region (aa 124 to 151) and the F protein heptad repeat 2 (HR2) at
position 454 to 492 [70,71]. In these regions, the MG strains show
amino acids substitutions at position E
147RD, K
476RNo fH N
and F proteins, respectively. Morrison and Gravel [72] have
demonstrated that amino acid substitutions in the head region
domain of HN protein as L
133RIo rA
140RL were responsible for
an enhanced or diminished virus attachment activity, respectively.
The possibility that other mutations like E
147RD e/or K
476RNi n
the same or related functional region may also contribute to
virulence or immune evasion cannot be ruled out. In addition, the
MG isolates display other specific mutations, some of them
affecting the head of HN. It is tempting to postulate that these
modifications (F or HN genes) may play a role in virulence or
Figure 3. Phylogenetic tree of the nucleotide sequences based on a 14977nt (NP/P/M/F/HN/L genes). The evolutionary history was
inferred using the Neighbor-Joining method [33]. All results are based on the pairwise analysis. Analyses were conducted using the Kimura 2-
parameter method in MEGA4 [31,32] with 1,000 bootstraps [76]. The isolates from Madagascar that were subjected to analysis in this work are in blue
[22]. Genotype and the lineage groupings are indicated on the right.
doi:10.1371/journal.pone.0013987.g003
Table 3. Matrix estimate of genetic divergence (%) between nucleotide sequences (374 nt) of NDV strains.
Genotypes XI I II H(w) III IV V VI VII VIII IX X CI
***
XI 5*
I 20** 7
II 25 12 2
H(w) 21 15 16 0
III 15 12 17 15 1
IV 12 12 17 15 6 7
V 19 16 19 18 14 11 5
VI 18 16 19 18 14 11 11 7
VII 21 18 21 21 17 14 14 3 7
VIII 22 17 20 17 14 13 11 12 15 9
IX 15 13 17 14 10 9 14 14 17 16 1
X 15 18 19 21 15 13 19 19 19 19 15 3
CI 50 46 51 50 48 47 47 46 47 48 49 52 7
*Intragenotype or intrasubgenotype: Maximal value of Nucleotide genetic divergence.
**Intergenotype: Minimal value of genetic divergence.
***Class I.
All results are based on the pairwise analysis of 61 NDV sequences including the 4 MG isolates (genotype XI). The nucleic acid analyse were conducted using Kimura 2-
parameter method in MEGA4 [31,78]. All positions containing alignment gaps and missing data were eliminated only in pairwise sequence comparisons (Pairwise
deletion option). There were a total of 374 nt positions in the final dataset.
doi:10.1371/journal.pone.0013987.t003
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PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e13987emergence of escape mutants and finally the apparent lack of
vaccine efficacy observed in the field.
The number of unique motifs found in all MG isolates,
including the atypical F protein cleavage site R-R-R-R-R*F-V,
also suggests a monophyletic origin of these viruses. Under this
hypothesis, the maximum genetic variation observed within MG
isolates (5%) is compatible with a divergence from a common
ancestor over 50 years, considering that the rate of nucleotide
change is approximately 1% per decade under natural field
conditions in epizootic periods [12,57]. This scenario is in
agreement with the first introduction of an old genotype of
NDV in Madagascar in 1946. However, the higher genetic
variation (12%) observed between the genotype XI and its closely
related genotype IV suggests that the common ancestor of these
two genotypes may have emerged several decades before the
introduction of its virus progeny in Madagascar. As mentioned
before, the accumulation of multiple aa substitutions in F or HN
proteins may also result from the immune pressure that can
contribute to increase the phylogenetic distance between the MG
group and its progenitor genotype. The presence of this selection
pressure at specific amino acid sites are recognised as adaptive
evolution [47,73]. This abnormal evolution rate of genotype XI
with regard to genotype IV may originate from combined
characteristics of current poultry production systems including
the commercial farm with host genetic homogeneity, intensive
and/or improperly executed vaccination programs and backyard
poultry breeding with high density of birds (allowing close animal-
to-animal contact, and favouring transmission of highly virulent
virus over milder forms) [74]. Moreover, high phylogenetic and
antigenic distances between vaccines and circulating strains may
facilitate the evolution of virulent NDV [75].
In conclusion, all four isolates from Madagascar were clustered in
a new genotype XI, presumably deriving from an ancestor close to
genotype IV introduced in the 50’s and possibly resulting from a
self-contained evolution due to geographical and ecological
characteristics of this island. The particular evolution of genotype
XI in Madagascar reinforces the idea that this island, known for its
outstanding flora and fauna biodiversity, is also a unique ‘‘natural
ecosystem’’ for micro-organisms. Other genotypes like genotypes I,
II, III and VII were also detected in the island (data not shown).
These genotypes may have been introduced more recently in the
island, probably as a consequence of poultry import or use of live
vaccine strains. The co-circulation of different genotypes at the
same time and other introductions of new viruses in relation with
the worldwide intensification of animal movements, may contribute
inthefutureto dramatically increase thecomplexity of the situation.
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